nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—CYP2C9—brain cancer	0.927	1	CbGaD
Cyclizine—Altered state of consciousness—Temozolomide—brain cancer	0.00253	0.0357	CcSEcCtD
Cyclizine—Disorientation—Lomustine—brain cancer	0.00247	0.0348	CcSEcCtD
Cyclizine—Blister—Hydroxyurea—brain cancer	0.00207	0.0292	CcSEcCtD
Cyclizine—Hepatic function abnormal—Procarbazine—brain cancer	0.0016	0.0226	CcSEcCtD
Cyclizine—Disorientation—Procarbazine—brain cancer	0.00157	0.0221	CcSEcCtD
Cyclizine—Speech disorder—Carmustine—brain cancer	0.0014	0.0198	CcSEcCtD
Cyclizine—Speech disorder—Temozolomide—brain cancer	0.00136	0.0191	CcSEcCtD
Cyclizine—Disorientation—Hydroxyurea—brain cancer	0.00121	0.0171	CcSEcCtD
Cyclizine—Injection site reaction—Carmustine—brain cancer	0.0012	0.0169	CcSEcCtD
Cyclizine—Depressed level of consciousness—Carmustine—brain cancer	0.00117	0.0164	CcSEcCtD
Cyclizine—Dermatitis bullous—Hydroxyurea—brain cancer	0.00113	0.016	CcSEcCtD
Cyclizine—Depressed level of consciousness—Temozolomide—brain cancer	0.00113	0.0159	CcSEcCtD
Cyclizine—Apnoea—Etoposide—brain cancer	0.0011	0.0155	CcSEcCtD
Cyclizine—Drowsiness—Procarbazine—brain cancer	0.00108	0.0152	CcSEcCtD
Cyclizine—Pain—Carboplatin—brain cancer	0.00106	0.015	CcSEcCtD
Cyclizine—Thrombophlebitis—Carmustine—brain cancer	0.00101	0.0143	CcSEcCtD
Cyclizine—Thrombophlebitis—Temozolomide—brain cancer	0.000978	0.0138	CcSEcCtD
Cyclizine—Chills—Procarbazine—brain cancer	0.000869	0.0123	CcSEcCtD
Cyclizine—Drowsiness—Hydroxyurea—brain cancer	0.000835	0.0118	CcSEcCtD
Cyclizine—Tension—Procarbazine—brain cancer	0.000828	0.0117	CcSEcCtD
Cyclizine—Nervousness—Procarbazine—brain cancer	0.000819	0.0116	CcSEcCtD
Cyclizine—Tremor—Procarbazine—brain cancer	0.00079	0.0112	CcSEcCtD
Cyclizine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00079	0.0111	CcSEcCtD
Cyclizine—Convulsion—Procarbazine—brain cancer	0.000731	0.0103	CcSEcCtD
Cyclizine—Hypertension—Procarbazine—brain cancer	0.000728	0.0103	CcSEcCtD
Cyclizine—Chills—Hydroxyurea—brain cancer	0.000673	0.00949	CcSEcCtD
Cyclizine—Tachycardia—Procarbazine—brain cancer	0.000672	0.00948	CcSEcCtD
Cyclizine—Erythema—Hydroxyurea—brain cancer	0.000653	0.00921	CcSEcCtD
Cyclizine—Hypotension—Procarbazine—brain cancer	0.000643	0.00908	CcSEcCtD
Cyclizine—Phenprocoumon—CYP2C9—brain cancer	0.000623	0.236	CrCbGaD
Cyclizine—Insomnia—Procarbazine—brain cancer	0.000623	0.00879	CcSEcCtD
Cyclizine—Paraesthesia—Procarbazine—brain cancer	0.000618	0.00872	CcSEcCtD
Cyclizine—Hepatobiliary disease—Temozolomide—brain cancer	0.000617	0.00871	CcSEcCtD
Cyclizine—Somnolence—Procarbazine—brain cancer	0.000612	0.00864	CcSEcCtD
Cyclizine—Connective tissue disorder—Carmustine—brain cancer	0.000596	0.00841	CcSEcCtD
Cyclizine—Constipation—Procarbazine—brain cancer	0.000589	0.00831	CcSEcCtD
Cyclizine—Pain—Procarbazine—brain cancer	0.000589	0.00831	CcSEcCtD
Cyclizine—Hepatitis—Temozolomide—brain cancer	0.000586	0.00827	CcSEcCtD
Cyclizine—Bronchospasm—Etoposide—brain cancer	0.000576	0.00813	CcSEcCtD
Cyclizine—Connective tissue disorder—Temozolomide—brain cancer	0.000576	0.00812	CcSEcCtD
Cyclizine—Eye disorder—Carmustine—brain cancer	0.000567	0.00799	CcSEcCtD
Cyclizine—Convulsion—Hydroxyurea—brain cancer	0.000566	0.00798	CcSEcCtD
Cyclizine—Flunarizine—CYP2C9—brain cancer	0.000554	0.21	CrCbGaD
Cyclizine—Eye disorder—Temozolomide—brain cancer	0.000547	0.00773	CcSEcCtD
Cyclizine—Urticaria—Procarbazine—brain cancer	0.000547	0.00772	CcSEcCtD
Cyclizine—Mental disorder—Carmustine—brain cancer	0.000531	0.00749	CcSEcCtD
Cyclizine—Erythema—Carmustine—brain cancer	0.000528	0.00745	CcSEcCtD
Cyclizine—Chills—Temozolomide—brain cancer	0.000526	0.00742	CcSEcCtD
Cyclizine—Nervous system disorder—Hydroxyurea—brain cancer	0.000522	0.00737	CcSEcCtD
Cyclizine—Skin disorder—Hydroxyurea—brain cancer	0.000518	0.0073	CcSEcCtD
Cyclizine—Mental disorder—Temozolomide—brain cancer	0.000513	0.00724	CcSEcCtD
Cyclizine—Erythema—Temozolomide—brain cancer	0.00051	0.0072	CcSEcCtD
Cyclizine—Hypersensitivity—Procarbazine—brain cancer	0.000507	0.00716	CcSEcCtD
Cyclizine—Vision blurred—Carmustine—brain cancer	0.000497	0.00702	CcSEcCtD
Cyclizine—Tremor—Carmustine—brain cancer	0.000494	0.00698	CcSEcCtD
Cyclizine—Asthenia—Procarbazine—brain cancer	0.000494	0.00697	CcSEcCtD
Cyclizine—Hepatobiliary disease—Etoposide—brain cancer	0.000494	0.00697	CcSEcCtD
Cyclizine—Agranulocytosis—Etoposide—brain cancer	0.000487	0.00688	CcSEcCtD
Cyclizine—Pruritus—Procarbazine—brain cancer	0.000487	0.00687	CcSEcCtD
Cyclizine—Agitation—Carmustine—brain cancer	0.000485	0.00684	CcSEcCtD
Cyclizine—Vision blurred—Temozolomide—brain cancer	0.000481	0.00678	CcSEcCtD
Cyclizine—Tremor—Temozolomide—brain cancer	0.000478	0.00674	CcSEcCtD
Cyclizine—Somnolence—Hydroxyurea—brain cancer	0.000474	0.00668	CcSEcCtD
Cyclizine—Agitation—Temozolomide—brain cancer	0.000469	0.00661	CcSEcCtD
Cyclizine—Angioedema—Temozolomide—brain cancer	0.000466	0.00658	CcSEcCtD
Cyclizine—Convulsion—Carmustine—brain cancer	0.000457	0.00645	CcSEcCtD
Cyclizine—Hypertension—Carmustine—brain cancer	0.000456	0.00643	CcSEcCtD
Cyclizine—Pain—Hydroxyurea—brain cancer	0.000456	0.00643	CcSEcCtD
Cyclizine—Constipation—Hydroxyurea—brain cancer	0.000456	0.00643	CcSEcCtD
Cyclizine—Dizziness—Procarbazine—brain cancer	0.000455	0.00642	CcSEcCtD
Cyclizine—Modafinil—CYP2C9—brain cancer	0.000453	0.172	CrCbGaD
Cyclizine—Convulsion—Temozolomide—brain cancer	0.000442	0.00623	CcSEcCtD
Cyclizine—Hypertension—Temozolomide—brain cancer	0.00044	0.00621	CcSEcCtD
Cyclizine—Cinnarizine—CYP2C9—brain cancer	0.000438	0.166	CrCbGaD
Cyclizine—Eye disorder—Etoposide—brain cancer	0.000438	0.00618	CcSEcCtD
Cyclizine—Headache—Procarbazine—brain cancer	0.000431	0.00609	CcSEcCtD
Cyclizine—Chills—Etoposide—brain cancer	0.000421	0.00594	CcSEcCtD
Cyclizine—Tachycardia—Carmustine—brain cancer	0.00042	0.00593	CcSEcCtD
Cyclizine—Anaphylactic shock—Temozolomide—brain cancer	0.000416	0.00587	CcSEcCtD
Cyclizine—Nervous system disorder—Temozolomide—brain cancer	0.000408	0.00576	CcSEcCtD
Cyclizine—Skin disorder—Temozolomide—brain cancer	0.000404	0.0057	CcSEcCtD
Cyclizine—Hypotension—Carmustine—brain cancer	0.000402	0.00568	CcSEcCtD
Cyclizine—Hypersensitivity—Hydroxyurea—brain cancer	0.000393	0.00554	CcSEcCtD
Cyclizine—Muscle spasms—Etoposide—brain cancer	0.000392	0.00554	CcSEcCtD
Cyclizine—Insomnia—Carmustine—brain cancer	0.00039	0.0055	CcSEcCtD
Cyclizine—Paraesthesia—Carmustine—brain cancer	0.000387	0.00546	CcSEcCtD
Cyclizine—Somnolence—Carmustine—brain cancer	0.000383	0.0054	CcSEcCtD
Cyclizine—Asthenia—Hydroxyurea—brain cancer	0.000382	0.00539	CcSEcCtD
Cyclizine—Insomnia—Temozolomide—brain cancer	0.000376	0.00531	CcSEcCtD
Cyclizine—Paraesthesia—Temozolomide—brain cancer	0.000374	0.00527	CcSEcCtD
Cyclizine—Somnolence—Temozolomide—brain cancer	0.00037	0.00522	CcSEcCtD
Cyclizine—Pain—Carmustine—brain cancer	0.000368	0.0052	CcSEcCtD
Cyclizine—Constipation—Carmustine—brain cancer	0.000368	0.0052	CcSEcCtD
Cyclizine—Pain—Temozolomide—brain cancer	0.000356	0.00502	CcSEcCtD
Cyclizine—Constipation—Temozolomide—brain cancer	0.000356	0.00502	CcSEcCtD
Cyclizine—Convulsion—Etoposide—brain cancer	0.000354	0.00499	CcSEcCtD
Cyclizine—Hypertension—Etoposide—brain cancer	0.000352	0.00497	CcSEcCtD
Cyclizine—Dizziness—Hydroxyurea—brain cancer	0.000352	0.00497	CcSEcCtD
Cyclizine—Headache—Hydroxyurea—brain cancer	0.000334	0.00471	CcSEcCtD
Cyclizine—Anaphylactic shock—Etoposide—brain cancer	0.000333	0.0047	CcSEcCtD
Cyclizine—Urticaria—Temozolomide—brain cancer	0.000331	0.00467	CcSEcCtD
Cyclizine—Tachycardia—Etoposide—brain cancer	0.000325	0.00459	CcSEcCtD
Cyclizine—Skin disorder—Etoposide—brain cancer	0.000324	0.00456	CcSEcCtD
Cyclizine—Hypersensitivity—Carmustine—brain cancer	0.000317	0.00448	CcSEcCtD
Cyclizine—Diphenhydramine—CYP2C9—brain cancer	0.000315	0.119	CrCbGaD
Cyclizine—Hypotension—Etoposide—brain cancer	0.000311	0.00439	CcSEcCtD
Cyclizine—Asthenia—Carmustine—brain cancer	0.000309	0.00436	CcSEcCtD
Cyclizine—Hypersensitivity—Temozolomide—brain cancer	0.000307	0.00433	CcSEcCtD
Cyclizine—Paraesthesia—Etoposide—brain cancer	0.000299	0.00422	CcSEcCtD
Cyclizine—Asthenia—Temozolomide—brain cancer	0.000299	0.00421	CcSEcCtD
Cyclizine—Somnolence—Etoposide—brain cancer	0.000296	0.00418	CcSEcCtD
Cyclizine—Pruritus—Temozolomide—brain cancer	0.000294	0.00416	CcSEcCtD
Cyclizine—Dizziness—Carmustine—brain cancer	0.000285	0.00402	CcSEcCtD
Cyclizine—Pain—Etoposide—brain cancer	0.000285	0.00402	CcSEcCtD
Cyclizine—Constipation—Etoposide—brain cancer	0.000285	0.00402	CcSEcCtD
Cyclizine—Dizziness—Temozolomide—brain cancer	0.000275	0.00388	CcSEcCtD
Cyclizine—Headache—Carmustine—brain cancer	0.00027	0.00381	CcSEcCtD
Cyclizine—Urticaria—Etoposide—brain cancer	0.000265	0.00373	CcSEcCtD
Cyclizine—Headache—Temozolomide—brain cancer	0.000261	0.00368	CcSEcCtD
Cyclizine—Clozapine—CYP2C9—brain cancer	0.000254	0.0963	CrCbGaD
Cyclizine—Hypersensitivity—Etoposide—brain cancer	0.000245	0.00346	CcSEcCtD
Cyclizine—Asthenia—Etoposide—brain cancer	0.000239	0.00337	CcSEcCtD
Cyclizine—Pruritus—Etoposide—brain cancer	0.000236	0.00332	CcSEcCtD
Cyclizine—Dizziness—Etoposide—brain cancer	0.00022	0.00311	CcSEcCtD
Cyclizine—Headache—Etoposide—brain cancer	0.000209	0.00294	CcSEcCtD
